US2006063248A1PendingUtilityA1

Butyrylcholinesterase variants and methods of use

Assignee: LOCKRIDGE OKSANAPriority: Dec 26, 2000Filed: Sep 21, 2005Published: Mar 23, 2006
Est. expiryDec 26, 2020(expired)· nominal 20-yr term from priority
C12Q 1/46C12N 9/18A61K 38/00C12Y 301/01008
53
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The invention provides four butyrylcholinesterase variants having increased cocaine hydrolysis activity as well as the corresponding encoding nucleic acids. The invention also provides libraries comprising butyrylcholinesterase variants having at least one amino acid alteration in one or more regions of butyrylcholinesterase and further having at least one butyrylcholinesterase variant exhibiting enhanced cocaine hydrolysis activity compared to butyrylcholinesterase. The invention further provides methods of hydrolyzing a cocaine-based butyrylcholinesterase substrate as well as methods of treating a cocaine-induced condition.

Claims

exact text as granted — not AI-modified
1 - 3 . (canceled)  
     
     
         4 . A butyrylcholinesterase variant comprising the amino acid sequence shown as SEQ ID NO: 4.  
     
     
         5 . The butyrylcholinesterase variant of  claim 4 , having a four-fold increase in cocaine hydrolysis activity.  
     
     
         6 . A nucleic acid encoding a butyrylcholinesterase variant comprising the nucleic acid sequence shown as SEQ ID NO: 3.  
     
     
         7 - 39 . (canceled)

Join the waitlist — get patent alerts

Track US2006063248A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.